Nuanwan Rujirekasuwan

Nuanwan Rujirekasuwan

Auto-generated profile, based on publicly available information

Nuanwan Rujirekasuwan

Kasetsart University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2024 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
NRNuanwan Rujirekasuwan
Nuanwan Rujirekasuwan
panpicha sattasathuchanapanpicha sattasathuchana
panpicha sattasathuchana
WTWUTTHIWONG THEERAPAN
WUTTHIWONG THEERAPAN
NTNaris Thengchaisri
Naris Thengchaisri

18 March 2025 in Veterinary World
Verified
Journal Article
Open access
CTChatrawee Tuaktaew
Chatrawee Tuaktaew
NSNatthanet Sritrakoon
Natthanet Sritrakoon
WKWinyu Karntip
Winyu Karntip
NRNuanwan Rujirekasuwan
Nuanwan Rujirekasuwan
NNNuttatida Nimitchaiyapong
Nuttatida Nimitchaiyapong
Burin NimsuphanBurin Nimsuphan
Burin Nimsuphan
Background and Aim: Glaucoma is a neurodegenerative disease characterized by elevated intraocular pressure (IOP) and can lead to irreversible blindness in dogs. Cyclocryotherapy, a cyclodestructive surgical technique, reduces IOP by damaging the ciliary body epithelium to decrease aqueous humor production. Limited data exist on its clinical outcomes and complications in canine patients. This study aimed to evaluate the efficacy and post-operative complications of cyclocryotherapy in dogs with primary and secondary glaucoma. Materials and Methods: A retrospective analysis was conducted on the medical records of 73 eyes from 58 dogs treated with cyclocryotherapy at Kasetsart University Veterinary Teaching Hospital (2018–2023). The procedure involved applying a double cycle of freezing and thawing using a cryoprobe on 8–10 scleral sites. Evaluations occurred at weeks 1 and 2, then at 1, 3, and 6 months post-operatively. Data collected included IOP, anti-glaucoma medication use, post-operative complications, and vision status. Statistical analyses involved paired t-tests, Chi-square tests, and repeated measures analysis of variance. Results: Primary glaucoma was present in 40 eyes (54.79%) and secondary glaucoma in 33 eyes (45.21%). Mean pre-operative IOP for primary and secondary glaucoma was 42 ± 36 mmHg and 50.7 ± 14.5 mmHg, respectively, significantly decreasing to 18.3 ± 12.84 mmHg and 14.42 ± 12.06 mmHg at the final follow-up (p < 0.001). The success rate was 83.56%, with 92.30% of eyes preserving vision. Post-operative complications occurred in 50% of cases, primarily conjunctivitis (28.76%). The frequency of anti-glaucoma medication use significantly decreased in both groups (p < 0.001). Conclusion: Cyclocryotherapy effectively manages canine glaucoma, significantly reducing IOP and medication dependence while preserving vision in most cases. Although complications were noted, they were generally manageable. Prospective studies are recommended to refine treatment protocols and validate these findings. Keywords: cyclocryotherapy, dogs, glaucoma, intraocular pressure, veterinary ophthalmology.

17 August 2026 in Veterinary World
Verified
Journal Article
Open access
PDF file
PSPasinee Sakulchatwut
Pasinee Sakulchatwut
NSNatthanet Sritrakoon
Natthanet Sritrakoon
NRNuanwan Rujirekasuwan
Nuanwan Rujirekasuwan
TTTikamporn Teekasang
Tikamporn Teekasang
MSMananya Sakulchatwut
Mananya Sakulchatwut
SNSirirat Niyom
Sirirat Niyom
Background and Aim: Sudden acquired retinal degeneration syndrome (SARDS) is an important cause of acute, irreversible blindness in dogs and is frequently accompanied by systemic clinical and biochemical abnormalities. Despite numerous studies describing the disease, no clinically applicable prediction tool has been developed to facilitate early recognition before electroretinographic confirmation. This study aimed to identify demographic, hematological, and biochemical factors associated with SARDS and to develop and internally validate a practical clinical risk score for early identification of affected dogs. Materials and Methods: A retrospective case–control study was conducted using medical records of dogs that underwent electroretinography between January 2018 and December 2023 at the Kasetsart University Veterinary Teaching Hospital in Thailand. Fifty-three dogs with electroretinography-confirmed SARDS were compared with 219 breed-frequency-matched cataract patients exhibiting normal electroretinographic responses. Demographic characteristics, complete blood count results, and serum biochemical parameters were analyzed. Variables associated with SARDS in univariable logistic regression (p < 0.20) were entered into multivariable logistic regression using a manual purposeful selection approach. Independent predictors were incorporated into a weighted clinical risk score. Diagnostic performance was evaluated using receiver operating characteristic analysis, sensitivity, specificity, and area under the receiver operating characteristic curve (AuROC). Results: Dogs with SARDS exhibited significantly higher neutrophil counts, alkaline phosphatase (ALP) activity, plasma protein concentration, alanine aminotransferase activity, creatinine concentration, and white blood cell counts than control dogs. Multivariable logistic regression identified elevated neutrophil count (odds ratio [OR] = 8.80; p < 0.001), elevated ALP activity (OR = 6.80; p < 0.001), and increased plasma protein concentration (OR = 3.94; p = 0.004) as independent predictors of SARDS. Based on optimal cutoff values (neutrophils ≥10,525 cells/μL, ALP ≥74 U/L, and plasma protein ≥7.3 g/dL), a weighted clinical risk score ranging from 0 to 5 points was developed. A threshold score of ≥3 demonstrated good discriminative ability, with an AuROC of 0.83 (95% confidence interval: 0.76–0.90), sensitivity of 74.47%, and specificity of 79.79%, outperforming each individual laboratory parameter. Conclusion: This study identified readily available hematological and biochemical variables that are independently associated with SARDS and developed the first weighted clinical risk score for early identification of the disease in dogs. The proposed model demonstrated good diagnostic performance and may assist veterinarians in prioritizing dogs for ophthalmic evaluation and electroretinography. Although external validation in independent populations is warranted, this practical scoring system represents a valuable adjunct for improving early clinical suspicion and diagnostic decision-making in canine SARDS. Keywords: alkaline phosphatase, clinical prediction model, dogs, electroretinography, hematology, risk factors, sudden acquired retinal degeneration syndrome.

17 August 2026 in Veterinary World
Verified
Journal Article
Open access
PDF file
PSPasinee Sakulchatwut
Pasinee Sakulchatwut
NSNatthanet Sritrakoon
Natthanet Sritrakoon
NRNuanwan Rujirekasuwan
Nuanwan Rujirekasuwan
TTTikamporn Teekasang
Tikamporn Teekasang
MSMananya Sakulchatwut
Mananya Sakulchatwut
SNSirirat Niyom
Sirirat Niyom
Background and Aim: Sudden acquired retinal degeneration syndrome (SARDS) is an important cause of acute, irreversible blindness in dogs and is frequently accompanied by systemic clinical and biochemical abnormalities. Despite numerous studies describing the disease, no clinically applicable prediction tool has been developed to facilitate early recognition before electroretinographic confirmation. This study aimed to identify demographic, hematological, and biochemical factors associated with SARDS and to develop and internally validate a practical clinical risk score for early identification of affected dogs. Materials and Methods: A retrospective case–control study was conducted using medical records of dogs that underwent electroretinography between January 2018 and December 2023 at the Kasetsart University Veterinary Teaching Hospital in Thailand. Fifty-three dogs with electroretinography-confirmed SARDS were compared with 219 breed-frequency-matched cataract patients exhibiting normal electroretinographic responses. Demographic characteristics, complete blood count results, and serum biochemical parameters were analyzed. Variables associated with SARDS in univariable logistic regression (p < 0.20) were entered into multivariable logistic regression using a manual purposeful selection approach. Independent predictors were incorporated into a weighted clinical risk score. Diagnostic performance was evaluated using receiver operating characteristic analysis, sensitivity, specificity, and area under the receiver operating characteristic curve (AuROC). Results: Dogs with SARDS exhibited significantly higher neutrophil counts, alkaline phosphatase (ALP) activity, plasma protein concentration, alanine aminotransferase activity, creatinine concentration, and white blood cell counts than control dogs. Multivariable logistic regression identified elevated neutrophil count (odds ratio [OR] = 8.80; p < 0.001), elevated ALP activity (OR = 6.80; p < 0.001), and increased plasma protein concentration (OR = 3.94; p = 0.004) as independent predictors of SARDS. Based on optimal cutoff values (neutrophils ≥10,525 cells/μL, ALP ≥74 U/L, and plasma protein ≥7.3 g/dL), a weighted clinical risk score ranging from 0 to 5 points was developed. A threshold score of ≥3 demonstrated good discriminative ability, with an AuROC of 0.83 (95% confidence interval: 0.76–0.90), sensitivity of 74.47%, and specificity of 79.79%, outperforming each individual laboratory parameter. Conclusion: This study identified readily available hematological and biochemical variables that are independently associated with SARDS and developed the first weighted clinical risk score for early identification of the disease in dogs. The proposed model demonstrated good diagnostic performance and may assist veterinarians in prioritizing dogs for ophthalmic evaluation and electroretinography. Although external validation in independent populations is warranted, this practical scoring system represents a valuable adjunct for improving early clinical suspicion and diagnostic decision-making in canine SARDS. Keywords: alkaline phosphatase, clinical prediction model, dogs, electroretinography, hematology, risk factors, sudden acquired retinal degeneration syndrome.